DEF 14A Filing

Company

Marker Therapeutics, Inc.

Filed

March 2, 2007

Period of Report

February 28, 2007

Accession Number

0001183740-07-000103

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →